- First line agent for Open Angle Glaucoma
- Active Uveitis
- Prostaglandin analogs that increase uveoscleral aqueous outflow (lowers IOP 25 to 35%)
- Latanoprost (Xalatan) 0.005% one drop daily
- Bimatoprost (Lumigan) 0.03% one drop daily
- Travoprost (Travatan) 0.004% one drop daily
- Unoprostone (Rescula) 0.15% one drop daily
- Tafluprost (Zioptan) 0.0015% one drop daily
- Latanoprostene bunod (Vyzulta)
- Breaks down to Latanoprost and nitric oxide, but with no significant benefit over Latanoprost alone
- Released in 2018, costing 10x the cost of Latanoprost alone (which is $12 per bottle)
- (2018) Presc Lett 25(5): 28
- Latanoprost
- Highly effective, low side effect agent
- Currently most prescribed Glaucoma agent worldwide
- References